Yang Sai
Senior Vice President
Drug Metabolism and Pharmacokinetics
Pfizer
China
Biography
Dr. Sai has headed the drug metabolism, pharmacokinetics (DMPK) and drug safety evaluation teams since he established them in 2006. He leads these teams to process clinical pharmacology/pharmacokinetic studies for drug discovery and development. Dr. Sai spent 21 years at the Beijing Institute of Radiation Medicine, the National Institutes of Health, the University of Washington and Harvard University; and over 11 years of industrial experience, all in DMPK, pharmacology and safety evaluation. Immediately prior to joining in 2006, he was Principal Scientist at Neurocrine Biosciences. Dr. Sai earned his B.S. in pharmacy from the 2nd Military Medical University, his M.S. in pharmacology and toxicology from the Beijing Institute of Radiation Medicine, and earned his Ph.D. in biopharmacy from King’s College London, London University.
Research Interest
Drug Metabolism and Pharmacokinetics
